Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL, USA.
Centre for Cell Factories and Biopolymers, Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, Australia.
Nat Rev Microbiol. 2020 Apr;18(4):195-210. doi: 10.1038/s41579-019-0313-3. Epub 2020 Jan 28.
Bacteria are prime cell factories that can efficiently convert carbon and nitrogen sources into a large diversity of intracellular and extracellular biopolymers, such as polysaccharides, polyamides, polyesters, polyphosphates, extracellular DNA and proteinaceous components. Bacterial polymers have important roles in pathogenicity, and their varied chemical and material properties make them suitable for medical and industrial applications. The same biopolymers when produced by pathogenic bacteria function as major virulence factors, whereas when they are produced by non-pathogenic bacteria, they become food ingredients or biomaterials. Interdisciplinary research has shed light on the molecular mechanisms of bacterial polymer synthesis, identified new targets for antibacterial drugs and informed synthetic biology approaches to design and manufacture innovative materials. This Review summarizes the role of bacterial polymers in pathogenesis, their synthesis and their material properties as well as approaches to design cell factories for production of tailor-made bio-based materials suitable for high-value applications.
细菌是主要的细胞工厂,可以将碳氮源高效地转化为丰富多样的胞内和胞外生物聚合物,如多糖、聚酰胺、聚酯、多磷酸盐、胞外 DNA 和蛋白成分。细菌聚合物在致病性方面具有重要作用,其多样化的化学和材料性质使它们适用于医疗和工业应用。同样的生物聚合物在致病性细菌中产生时作为主要的毒力因子,而在非致病性细菌中产生时则成为食品成分或生物材料。跨学科研究揭示了细菌聚合物合成的分子机制,为抗菌药物的新靶点提供了依据,并为设计和制造用于高价值应用的创新材料的合成生物学方法提供了信息。本综述总结了细菌聚合物在发病机制中的作用、它们的合成以及它们的材料特性,以及设计用于生产定制生物基材料的细胞工厂的方法,这些材料适用于高价值应用。